{
    "eid": "2-s2.0-84995756461",
    "title": "Impact of the copper transporter protein 1 (CTR1) polymorphism on adverse events among advanced non- small cell lung cancer patients treated with carboplatin- gemcitabine regimen",
    "cover-date": "2016-01-01",
    "subject-areas": [
        {
            "$": "Public Health",
            "@code": "2739"
        },
        {
            "$": "Oncology",
            "@code": "2730"
        },
        {
            "$": "Cancer Research",
            "@code": "1306"
        },
        {
            "$": "Epidemiology",
            "@code": "2713"
        }
    ],
    "keywords": [
        "Advanced NSCLC",
        "Adverse events",
        "CTR1",
        "Platinum resistance"
    ],
    "authors": [
        "Siriluk Kumpiro"
    ],
    "citedby-count": 8,
    "ref-count": 9,
    "ref-list": [
        "Cisplatin resistance and opportunities for precision medicine",
        "Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer",
        "Copper deprivation modulates CTR1 and CUP1 expression and enhances cisplatin cytotoxicity in Saccharomyces cerevisiae",
        "Molecular mechanisms of resistance and toxicity associated with platinating agents",
        "First line chemotherapy in advanced or metastatic NSCLC",
        "Pharmacogenomics of cisplatin sensitivity in non-small cell lung cancer",
        "Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs",
        "Genetic polymorphism of copper transporter protein 1 is related to platinum resistance in Chinese non-small cell lung carcinoma patients",
        "Prediction of copper transport protein 1 (CTR1) genotype on severe cisplatin induced toxicity in non-small cell lung cancer (NSCLC) patients"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "affilname": "Chulalongkorn University",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Chulalongkorn University"
    ]
}